amyloid beta peptide modulator (BMS)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameamyloid beta peptide modulator (BMS)
Drug Alias NameAbeta modulator (Bristol-Myers Squibb)BMS-802299BMS-869780BMS-831929
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A